Treatment of diabetes, obesity and assessment of end organ damage (kidney and liver/intestine)
This symposium, organised by the Danish Diabetes Academy and DIABESITY, is intended for basic and clinical researchers, Ph.D.-students, medical students, industry trial planners and directors, industry technical staff working within any field of diabetes, including both clinical, basic and translational research/work and/or interdisciplinary research/work within fields related to diabetes.
The aim is to facilitate a high-quality symposium in the assessment and treatment of end organ damage in kidney and metabolic disease by providing new markers of interest, ultrasound and scanners and laboratory equipments of interest in kidney, liver and diabetes management and assessment.
Furthermore, to gain insight in gut peptide biology and clinical implications for diabetic and obese patients.
The meeting was held on June 18-19, 2021 in Copenhagen (Denmark) as well as VIRTUALLY.